Investment Objective
To achieve substantial capital appreciation for shareholders through investments in well-selected US companies in the areas of Biotechnology and Technology. To obtain performance through a well-balanced portfolio with regard to the risk profile.

Investment Philosophy
Investments are being made after thorough analysis of potentially high quality companies in growing markets. The shareholder's interest in the portfolio companies is actively represented and the companies are closely monitored. Advice to the management of the companies is given and the growth of the company is reviewed.

Investment Manager
Peter Friedli has over 20 years of venture capital investment experience and has access to a broad range of highly experienced scientists and business professionals. He has successfully managed several investment companies.